Cerebral salt wasting
Electrolyte · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Renal sodium and volume loss following acute brain injury (notably subarachnoid haemorrhage) causing hyponatraemia with hypovolaemia; must be distinguished from SIADH (which is euvolaemic).
Red flags
- Seizures/coma from hyponatraemia
- Hypovolaemic shock
- Vasospasm risk in subarachnoid haemorrhage
- Rapid overcorrection
Assessment
Differential diagnosis
- SIADH
- Diuretic-induced hyponatraemia
- Adrenal insufficiency
- Diabetes insipidus (if treated with hypotonic fluid)
Investigations
- Serum sodium and osmolality, urine sodium and osmolality
- Assess volume status clinically (key differentiator from SIADH)
- U&E, urine output, fluid balance
- Cortisol/thyroid to exclude other causes
Management
- Assess volume status - CSW is hypovolaemic, SIADH is euvolaemic
- Replace sodium and volume with isotonic (or hypertonic if severe/symptomatic) saline
- Do NOT fluid-restrict (unlike SIADH)
- Fludrocortisone may reduce renal sodium loss
- Correct sodium at a safe rate to avoid osmotic demyelination
- Monitor closely and treat the underlying brain injury
Drugs & doses
Isotonic saline for volume and sodium replacement
Hypertonic (3%) saline if severe symptomatic hyponatraemia
Fludrocortisone (adjunct)
Avoid fluid restriction
Disposition
Admit; neuro/ICU; frequent sodium monitoring.
Complications & pitfalls
- Cerebral ischaemia/vasospasm
- Osmotic demyelination from overcorrection
- Hypovolaemic shock
Exam pearls
- Volume status is the key to distinguishing CSW from SIADH
- Fluid restriction (correct for SIADH) is dangerous in CSW and vasospasm
- Correct sodium slowly to prevent osmotic demyelination
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.